EE200000658A - CD23 antikehad, nende derivaadid ja nende terapeutiline kasutamine - Google Patents
CD23 antikehad, nende derivaadid ja nende terapeutiline kasutamineInfo
- Publication number
- EE200000658A EE200000658A EEP200000658A EEP200000658A EE200000658A EE 200000658 A EE200000658 A EE 200000658A EE P200000658 A EEP200000658 A EE P200000658A EE P200000658 A EEP200000658 A EE P200000658A EE 200000658 A EE200000658 A EE 200000658A
- Authority
- EE
- Estonia
- Prior art keywords
- antibodies
- derivatives
- therapeutic use
- therapeutic
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2851—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against the lectin superfamily, e.g. CD23, CD72
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB9809839.5A GB9809839D0 (en) | 1998-05-09 | 1998-05-09 | Antibody |
| PCT/GB1999/001434 WO1999058679A1 (en) | 1998-05-09 | 1999-05-07 | Antibodies to cd23, derivatives thereof, and their therapeutic uses |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EE200000658A true EE200000658A (et) | 2002-04-15 |
Family
ID=10831668
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EEP200000658A EE200000658A (et) | 1998-05-09 | 1999-05-07 | CD23 antikehad, nende derivaadid ja nende terapeutiline kasutamine |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US7008623B1 (tr) |
| EP (1) | EP1076701A1 (tr) |
| JP (1) | JP2002514421A (tr) |
| KR (1) | KR20010043470A (tr) |
| CN (1) | CN1308676A (tr) |
| AP (1) | AP1547A (tr) |
| AU (1) | AU763491B2 (tr) |
| BR (1) | BR9910327A (tr) |
| CA (1) | CA2328606A1 (tr) |
| EA (1) | EA200001041A1 (tr) |
| EE (1) | EE200000658A (tr) |
| GB (1) | GB9809839D0 (tr) |
| HR (1) | HRP20000762A2 (tr) |
| HU (1) | HUP0102005A3 (tr) |
| ID (1) | ID28088A (tr) |
| IL (1) | IL139384A0 (tr) |
| IS (1) | IS5696A (tr) |
| NO (1) | NO20005632L (tr) |
| NZ (1) | NZ507879A (tr) |
| PL (1) | PL344019A1 (tr) |
| SK (1) | SK16762000A3 (tr) |
| TR (1) | TR200003281T2 (tr) |
| WO (1) | WO1999058679A1 (tr) |
| YU (1) | YU69000A (tr) |
| ZA (1) | ZA200006312B (tr) |
Families Citing this family (45)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6696550B2 (en) | 1998-07-23 | 2004-02-24 | Millennium Pharmaceuticals, Inc. | Humanized anti-CCR2 antibodies and methods of use therefor |
| JP2004532608A (ja) | 2000-10-13 | 2004-10-28 | バイオジェン・アイデック・エムエイ・インコーポレイテッド | ヒト化抗ＬＴ−β−Ｒ抗体 |
| US20040151721A1 (en) | 2001-10-19 | 2004-08-05 | O'keefe Theresa | Humanized anti-CCR2 antibodies and methods of use therefor |
| EP1539793A4 (en) * | 2002-07-01 | 2006-02-01 | HUMANIZED ANTIBODIES AGAINST THE RECEPTOR OF LYMPHOTOXIN BETA | |
| AR040778A1 (es) | 2002-08-06 | 2005-04-20 | Glaxo Group Ltd | Anticuerpos alterados o fragmentos funcionales que se unen a mag (glicoproteina asociada a mielina). |
| GB0306309D0 (en) | 2003-03-19 | 2003-04-23 | Glaxo Group Ltd | Method of treatment |
| US20050163782A1 (en) | 2003-06-27 | 2005-07-28 | Biogen Idec Ma Inc. | Modified binding molecules comprising connecting peptides |
| CA2434668A1 (en) | 2003-07-04 | 2005-01-04 | Laurence Mulard | Novel approach to design glycopeptides based on o-specific polysaccharide of shigella flexneri serotype 2a |
| MXPA06000176A (es) * | 2003-12-10 | 2006-06-27 | Millennium Pharm Inc | Anticuerpos anti-ccr2 humanizados y sus metodos de uso. |
| US7435799B2 (en) * | 2004-01-08 | 2008-10-14 | Applied Molecular Evolution | TNF-α binding molecules |
| AU2005227322A1 (en) | 2004-03-23 | 2005-10-06 | Biogen Idec Ma Inc. | Receptor coupling agents and therapeutic uses thereof |
| US20060246075A1 (en) * | 2004-09-29 | 2006-11-02 | Marc Mercken | Anti-amyloid antibodies, compositions, methods and uses |
| WO2006074399A2 (en) | 2005-01-05 | 2006-07-13 | Biogen Idec Ma Inc. | Multispecific binding molecules comprising connecting peptides |
| AP2008004467A0 (en) * | 2005-11-14 | 2008-06-30 | Rinat Neurosciene Corp | Antagonist antibodies directed against calcitonin generelated peptide anf methods using same |
| GB0525662D0 (en) | 2005-12-16 | 2006-01-25 | Glaxo Group Ltd | Immunoglobulins |
| US7680868B2 (en) * | 2005-12-20 | 2010-03-16 | Roche Molecular Systems, Inc. | PCR elbow determination by use of a double sigmoid function curve fit with the Levenburg-Marquardt algorithm and normalization |
| EP1804172B1 (en) * | 2005-12-20 | 2021-08-11 | Roche Diagnostics GmbH | PCR elbow determination using curvature analysis of a double sigmoid |
| WO2009043051A2 (en) * | 2007-09-27 | 2009-04-02 | Biogen Idec Ma Inc. | Cd23 binding molecules and methods of use thereof |
| KR101710472B1 (ko) | 2007-11-30 | 2017-02-27 | 글락소 그룹 리미티드 | 항원-결합 작제물 |
| JP5537441B2 (ja) | 2008-03-04 | 2014-07-02 | ファイザー・リミテッド | 慢性疼痛を治療する方法 |
| US20110064821A1 (en) | 2008-05-06 | 2011-03-17 | Catchpole Ian Richard | Encapsulation of biologically active agents |
| WO2010097386A1 (en) | 2009-02-24 | 2010-09-02 | Glaxo Group Limited | Antigen-binding constructs |
| CA2753287A1 (en) | 2009-02-24 | 2010-09-02 | Glaxo Group Limited | Antigen-binding constructs |
| JP2012518400A (ja) | 2009-02-24 | 2012-08-16 | グラクソ グループ リミテッド | 多価および／または複数特異的ｒａｎｋｌ結合性構築物 |
| CA2757237A1 (en) | 2009-04-01 | 2010-10-14 | Jane Elizabeth Clarkson | Anti-il-23 immunoglobulins |
| US20120058116A1 (en) | 2009-04-24 | 2012-03-08 | Andrew Beaton | Fgfr1c antibody combinations |
| MX2012002464A (es) | 2009-08-28 | 2012-03-14 | Rinat Neuroscience Corp | El uso de anticuerpos antagonistas dirigidos contra el peptido relacionado con el gen de la calcitonina para tratar dolor visceral. |
| FR2957598B1 (fr) * | 2010-03-17 | 2015-12-04 | Lfb Biotechnologies | Nouveau peptide signal, et son utilisation pour la production de proteines recombinantes |
| JP6351973B2 (ja) | 2010-11-23 | 2018-07-04 | グラクソ グループ リミテッドＧｌａｘｏ Ｇｒｏｕｐ Ｌｉｍｉｔｅｄ | 抗原結合タンパク質 |
| BR112013013003A2 (pt) | 2010-11-24 | 2016-08-09 | Glaxo Group Ltd | proteína de ligação de antígeno, e, composição farmacêutica |
| US8974782B2 (en) | 2011-02-07 | 2015-03-10 | Glaxo Group Limited | Treatment of stroke comprising anti-MAG antibodies |
| DK3415531T3 (da) | 2011-05-27 | 2023-09-18 | Glaxo Group Ltd | Bcma (cd269/tnfrsf17)-bindende proteiner |
| WO2014029752A1 (en) | 2012-08-22 | 2014-02-27 | Glaxo Group Limited | Anti lrp6 antibodies |
| US10176293B2 (en) | 2012-10-02 | 2019-01-08 | Roche Molecular Systems, Inc. | Universal method to determine real-time PCR cycle threshold values |
| JP6224739B2 (ja) | 2013-03-15 | 2017-11-01 | グラクソスミスクライン、インテレクチュアル、プロパティー、ディベロップメント、リミテッドＧｌａｘｏｓｍｉｔｈｋｌｉｎｅ Ｉｎｔｅｌｌｅｃｔｕａｌ Ｐｒｏｐｅｒｔｙ Ｄｅｖｅｌｏｐｍｅｎｔ Ｌｉｍｉｔｅｄ | 抗ｌａｇ−３結合タンパク質 |
| ES2729317T3 (es) * | 2013-07-10 | 2019-10-31 | Onconox Aps | Anticuerpos a beta2-glicoproteína I y usos terapéuticos de estos |
| JP6568099B2 (ja) | 2014-03-21 | 2019-08-28 | テバ・ファーマシューティカルズ・インターナショナル・ゲーエムベーハーＴｅｖａ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ Ｉｎｔｅｒｎａｔｉｏｎａｌ ＧｍｂＨ | カルシトニン遺伝子関連ペプチドに対するアンタゴニスト抗体及びその使用方法 |
| US10556945B2 (en) | 2014-03-21 | 2020-02-11 | Teva Pharmaceuticals International Gmbh | Antagonist antibodies directed against calcitonin gene-related peptide and methods using same |
| PT3344654T (pt) | 2015-09-02 | 2021-01-26 | Immutep Sas | Anticorpos anti-lag-3 |
| JP6935184B2 (ja) * | 2016-05-31 | 2021-09-15 | シスメックス株式会社 | 糖ペプチドと反応するモノクローナル抗体およびその用途 |
| US10479827B2 (en) | 2016-05-31 | 2019-11-19 | Sysmex Corporation | Monoclonal antibody reacting with glycopeptide, and use thereof |
| KR102379464B1 (ko) | 2016-06-20 | 2022-03-29 | 키맵 리미티드 | 항-pd-l1 항체 |
| CA3036632A1 (en) | 2016-09-23 | 2018-03-29 | Teva Pharmaceuticals International Gmbh | Treating refractory migraine |
| WO2020261097A1 (en) | 2019-06-26 | 2020-12-30 | Glaxosmithkline Intellectual Property Development Limited | Il1rap binding proteins |
| CN112552403A (zh) * | 2020-12-25 | 2021-03-26 | 南京英瀚斯生物科技有限公司 | 一种人源抗人CD23抗体的Fab片段、药物组合物及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IE922437A1 (en) * | 1991-07-25 | 1993-01-27 | Idec Pharma Corp | Recombinant antibodies for human therapy |
| NZ243706A (en) | 1991-07-25 | 1994-08-26 | Idec Pharma Corp | Recombinant monkey antibodies, pharmaceutical compositions |
| DK0788513T3 (da) * | 1994-10-25 | 2001-04-02 | Glaxo Group Ltd | Anvendelse af bindingsmidler for CD23 i behandlingen af atoimmune sygdomme |
| US6011138A (en) * | 1997-02-20 | 2000-01-04 | Idec Pharmaceuticals Corporation | Gamma-1 anti-human CD23 monoclonal antibodies |
-
1998
- 1998-05-09 GB GBGB9809839.5A patent/GB9809839D0/en not_active Ceased
-
1999
- 1999-05-07 WO PCT/GB1999/001434 patent/WO1999058679A1/en not_active Application Discontinuation
- 1999-05-07 EA EA200001041A patent/EA200001041A1/ru unknown
- 1999-05-07 AP APAP/P/2000/001983A patent/AP1547A/en active
- 1999-05-07 PL PL99344019A patent/PL344019A1/xx unknown
- 1999-05-07 YU YU69000A patent/YU69000A/sh unknown
- 1999-05-07 SK SK1676-2000A patent/SK16762000A3/sk unknown
- 1999-05-07 HU HU0102005A patent/HUP0102005A3/hu unknown
- 1999-05-07 AU AU38367/99A patent/AU763491B2/en not_active Ceased
- 1999-05-07 CN CN99808452A patent/CN1308676A/zh active Pending
- 1999-05-07 IL IL13938499A patent/IL139384A0/xx unknown
- 1999-05-07 BR BR9910327-3A patent/BR9910327A/pt not_active Application Discontinuation
- 1999-05-07 US US09/674,716 patent/US7008623B1/en not_active Expired - Fee Related
- 1999-05-07 EP EP99920991A patent/EP1076701A1/en not_active Withdrawn
- 1999-05-07 ID IDW20002573A patent/ID28088A/id unknown
- 1999-05-07 TR TR2000/03281T patent/TR200003281T2/tr unknown
- 1999-05-07 JP JP2000548470A patent/JP2002514421A/ja not_active Ceased
- 1999-05-07 EE EEP200000658A patent/EE200000658A/xx unknown
- 1999-05-07 KR KR1020007012530A patent/KR20010043470A/ko not_active Application Discontinuation
- 1999-05-07 NZ NZ507879A patent/NZ507879A/xx unknown
- 1999-05-07 CA CA002328606A patent/CA2328606A1/en not_active Abandoned
-
2000
- 2000-10-31 IS IS5696A patent/IS5696A/is unknown
- 2000-11-03 ZA ZA200006312A patent/ZA200006312B/xx unknown
- 2000-11-08 NO NO20005632A patent/NO20005632L/no not_active Application Discontinuation
- 2000-11-09 HR HR20000762A patent/HRP20000762A2/hr not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| AU3836799A (en) | 1999-11-29 |
| ZA200006312B (en) | 2003-02-26 |
| HUP0102005A3 (en) | 2003-10-28 |
| EA200001041A1 (ru) | 2001-06-25 |
| CN1308676A (zh) | 2001-08-15 |
| AU763491B2 (en) | 2003-07-24 |
| ID28088A (id) | 2001-05-03 |
| SK16762000A3 (sk) | 2001-07-10 |
| GB9809839D0 (en) | 1998-07-08 |
| IS5696A (is) | 2000-10-31 |
| NZ507879A (en) | 2004-02-27 |
| TR200003281T2 (tr) | 2001-03-21 |
| HUP0102005A2 (hu) | 2001-10-28 |
| IL139384A0 (en) | 2001-11-25 |
| YU69000A (sh) | 2003-08-29 |
| CA2328606A1 (en) | 1999-11-18 |
| JP2002514421A (ja) | 2002-05-21 |
| US7008623B1 (en) | 2006-03-07 |
| HRP20000762A2 (en) | 2001-06-30 |
| PL344019A1 (en) | 2001-09-24 |
| WO1999058679A1 (en) | 1999-11-18 |
| NO20005632L (no) | 2001-01-08 |
| BR9910327A (pt) | 2001-01-30 |
| AP2000001983A0 (en) | 2000-12-31 |
| KR20010043470A (ko) | 2001-05-25 |
| AP1547A (en) | 2006-01-13 |
| EP1076701A1 (en) | 2001-02-21 |
| NO20005632D0 (no) | 2000-11-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EE200000658A (et) | CD23 antikehad, nende derivaadid ja nende terapeutiline kasutamine | |
| EE200200251A (et) | Uued N-asabitsükloamiidi derivaadid ja nende kasutamine | |
| EE200200175A (et) | Asendatud 2-tio-3,5-ditsüano-4-arüül-6-aminopüridiinid ja nende kasutamine | |
| EE04565B1 (et) | Adamantaani derivaadid, nende saamine ja kasutamine | |
| PT911340E (pt) | Isoquinolinas-3-carboxamidas substituidas, sua preparacao e utilizacao como farmacos | |
| IS5760A (is) | Meðferðarlegar bíarýl afleiður | |
| DK0869126T3 (da) | Dithiolanderivater, deres fremstilling og deres terapeutiske virkning | |
| EE04721B1 (et) | Fenüülksantiini derivaadid, nende valmistamismeetodid ja kasutamine | |
| NO20021379D0 (no) | Benzodiazepin-derivater, fremstilling og anvendelse derav | |
| NO980720D0 (no) | Pyridazin-3-on-derivater, deres anvendelse og mellomprodukter for deres fremstilling | |
| EE200300311A (et) | Ftalasinoon-piperidinoderivaadid, nende kasutamine ja ravim | |
| CY2013003I2 (el) | Φωσφονοκεφεμικα παραγωγα, διαδικασια για την παρασκευη τους, και χρηση αυτων | |
| EE200100470A (et) | Püridopüranoasepiini derivaadid, nende valmistamine ja terapeutiline kasutamine | |
| EE200000621A (et) | Pikornaviirusevastased ühendid, nende valmistamine ja kasutamine | |
| EE200000037A (et) | Atsüülpiperasinüülpürimidiinide derivaadid, nende valmistamine ja kasutamine ravimitena | |
| EE200200160A (et) | 2'-asendatud 1,1'-bifenüül-2-karboksamiidid, nende kasutamine ja farmatseutilised preparaadid | |
| FI956298A0 (fi) | 3-fenyyli-isokinolin-1(2H)-oneja, niiden valmistus ja terapeuttinen käyttö | |
| EE200100347A (et) | 3,3-biarüülpiperidiini ja 2,2-biarüülmorfoliini derivaadid | |
| DK1025100T3 (da) | 3-substituerede tetrahydropyridopyrimidinonderivater, fremstilling og anvendelsen heraf | |
| PT1178981E (pt) | 3-piridil-4-arilpirrois substituidos e metodos terapeuticos e profilacticos | |
| EE200000207A (et) | 8-asabitsüklo[3.2.1]oktaan-3-metaanamiini derivaadid, nende valmistamine ja terapeutiline kasutamine | |
| FI971317A (fi) | Uusia heterosyklisiä, substituoituja imidatsolokinoksalinoneja, niiden valmistus ja käyttö | |
| EE200000018A (et) | 6-pürrolidiin-2-üülpüridiinid, nende valmistamine ja terapeutiline kasutamine | |
| NO20006479D0 (no) | Tienopyridinforbindelser, deres fremstilling og anvendelse | |
| EE03441B1 (et) | 5-naftalen-1-üül-1,3-dioksaani derivaadid, nende valmistamine ja terapeutiline kasutamine |